These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6098118)

  • 21. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.
    Finklestein JZ; Albo V; Ertel I; Hammond D
    Cancer Chemother Rep; 1975; 59(2 Pt 1):351-7. PubMed ID: 167936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.
    Saylors RL; Stine KC; Sullivan J; Kepner JL; Wall DA; Bernstein ML; Harris MB; Hayashi R; Vietti TJ;
    J Clin Oncol; 2001 Aug; 19(15):3463-9. PubMed ID: 11481351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of cytotoxic drugs in the surgery of malignant disease.
    Watt J
    J Bone Joint Surg Br; 1968 Aug; 50(3):511-23. PubMed ID: 4303179
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of malignant tumors in infants with antineoplastic agents].
    Taguchi N
    Naika; 1968 Sep; 22(3):634-9. PubMed ID: 4303515
    [No Abstract]   [Full Text] [Related]  

  • 25. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxorubicin in treatment of malignant solid tumors in children.
    Pratt CB; Shanks EC
    Am J Dis Child; 1974 Apr; 127(4):534-6. PubMed ID: 4362485
    [No Abstract]   [Full Text] [Related]  

  • 27. CHEMOTHERAPY OF LOCALIZED INOPERABLE MALIGNANT TUMORS OF CHILDREN. PRELIMINARY REPORT.
    JAMES DH; GEORGE P; HUSTU O; WRENN E; BORELLA L; HERNANDEZ K; PINKEL D
    JAMA; 1964 Aug; 189():636-8. PubMed ID: 14162580
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
    Komp DM; Land VJ; Nitschke R; Cangir A; Dyment P
    Cancer Chemother Rep; 1975; 59(2 Pt 1):371-6. PubMed ID: 1097094
    [No Abstract]   [Full Text] [Related]  

  • 29. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R
    Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Side effects of cytostatic therapy in childhood].
    Blau HJ
    Kinderarztl Prax; 1976 Jun; 44(6):264-72. PubMed ID: 940289
    [No Abstract]   [Full Text] [Related]  

  • 32. [The treatment of some infantile malignant neoplasms with Vinca rosea alkaloids].
    Nigro N; Madon E
    Cancro; 1968; 21():Suppl 6:119+. PubMed ID: 4313386
    [No Abstract]   [Full Text] [Related]  

  • 33. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
    Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
    Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rhabdomyosarcoma--VAC regimen].
    Cho Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():661-4. PubMed ID: 25831844
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical use of actinomycin.
    Frei E
    Cancer Chemother Rep; 1974; 58(1):49-54. PubMed ID: 4130354
    [No Abstract]   [Full Text] [Related]  

  • 38. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
    Ikarashi Y; Kakihara T; Imai C; Tanaka A; Watanabe A; Uchiyama M
    Pediatr Int; 2004 Oct; 46(5):570-5. PubMed ID: 15491386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
    Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
    Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.